Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells

Cell Biology and Toxicology

Volumn 15, Issue 2, 1999, Pages 91-100

  Ouar, Z ^a   Lacave, R ^b   Bens, M ^a   Vandewalle, Alain ^a  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

Intracellular pH; Kidney cells; Lysosome; MDR; MRP; P glycoprotein

Indexed keywords

ABC TRANSPORTER; CYTOTOXIC AGENT; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; VINBLASTINE;

ANIMAL CELL; CANCER CELL; CELL PH; CONTROLLED STUDY; DRUG TRANSPORT; KIDNEY CELL; KIDNEY TUBULE CELL; LYSOSOME; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR FLUID; MICE; P-GLYCOPROTEIN;

EID: 0033043451     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007521430236     Document Type: Review

References (75)

1. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SP, Deeley RG. Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res. 1995;55:102-10.
2. Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med. 1998;187:1583-98.
3. Altenberg GA, Young G, Horton JK, Glass D, Belli JA, Reuss L. Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance. Proc Natl Acad Sci USA. 1993;90:9735-8.
4. Ambudkar SV, Lelong IH, Zhang J, Cardarelli CO, Gottesman MM, Pastan I. Partial purification of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci USA. 1992;89:8472-6.
5. Bauman PA, Dalton WS, Anderson JM, Cress AE. Expression of cytokeratin confers multidrug resistance. Proc Natl Acad Sci USA. 1994;91:5311-4.
6. Beck WT. The cell biology of multiple drug resistance. Biochem Pharmacol. 1987;36:2879-87.
7. Beck WT. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. J Natl Cancer Inst. 1989;81:1683-5.
8. Bellamy WT, Dalton WS. Multidrug resistance in the laboratory and clinic. Adv Clin Chem. 1994;31:1-61.
9. Bornmann WG, Roepe PD. Analysis of drug transport kinetics in multidrug resistant cell using a novel coumarin-vinblastine compound. Biochemistry. 1994;33:12665-75.
10. Borst P, Schinkel AH. Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet. 1997;13:217-22.
11. Borst P, Kool M, Evers R. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?. Semin Cancer Biol. 1997;8:205-13.
12. Boscoboinik D, Guppta RS, Epand RM. Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells. Br J Cancer. 1990;61:568-72.
13. Büchler M, König J, Brom M et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMRP, reveals a novel conjugate export pump deficient in hyperbilirubinemic rats. J Biol Chem. 1996;271: 15091-8.
14. Cartier N, Lacave R, Vallet V et al. Establishment of proximal tubule cell lines by targeted oncogenesis in transgenic mice using the L-pyruvate kinase-SV40 (T) antigen hybrid gene. J Cell Sci. 1993;104:695-704.
15. Chen CJ, Chin JE, Ueda K et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986;47:381-9.
16. Cole SPC, Downes HF, Mirski SEL, Clements DJ. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line. Mol Pharmacol. 1990;37:192-7.
17. Cole SPC, Bhardwaj G, Gerlach JH et al. Overexpression of a transporter gene in a multidrug-resistant human cancer cell line. Science (Washington DC). 1992;258:1650-4.
18. Cole SPC, Sparks K, Frazer K et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 1994;54:5902-10.
19. Coley HM, Amos WB, Twentyman PR, Workman P. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer. 1993; 67:1316-23.
20. Cordon-Cardo C, O'Brien JP, Casals D et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA. 1989;86:695-8.
21. Doige CA, Yu X, Sharom FJ. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim Biophys Acta. 1992;1109: 140-60.
22. Endicott JA, Ling V. The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem. 1989;58:137-71.
23. Epand RF, Epand RM, Gupta RS, Cragoe EJ Jr. Reversal of intrinsic multidrug resistance in Chinese hamster ovary cells by amiloride analogs. Br J Cancer. 1991;63:247-51.
24. Ernest S, Bello-Reuss E. Expression and function of P-glycoprotein in a mouse kidney cell line. Am J Physiol. 1995;269: C323-33.
25. Evans CD, Mirski SEL, Danks MK, Cole SPC. Reduced levels of topoisomerase II α and β in a multiple resistant small cell lung cancer cell line. Cancer Chemother Pharmacol. 1994; 34:242-8.
26. Evers R, Zaman GJR, van Deemter L et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest. 1996;97:1211-8.
27. Evers R, Kool M, van Deemter L et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest. 1998;101:1310-9.
28. Flens MJ, Zaman GJR, van der Valk P et al. Tissue distribution of the multidrug resistance protein. Am J Pathol. 1996;148: 1237-47.
29. Gottesman MM, Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem. 1988;263:12163-6.
30. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385-427.
31. Gros P, Buschman E. The mouse multidrug resistance gene family: structural and functional analysis. International Review of Cytology. A survey of cell biology. In: Friedlander M, Mueckler M, eds. Molecular biology of receptors and transporters, pumps, transporters and channels. San Diego: Academic Press; 1993:169-97.
32. Gros P, Croop J, Housman DE. Mammalian multidrug resistant gene: complete cDNA sequence indicating strong homology to bacterial transport proteins. Cell. 1986;47: 371-80.
33. Harris AL, Hochhauser D. Mechanisms of multidrug resistance in cancer treatment. Acta Oncologica. 1992;31:205-13.
34. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67-113.
35. Higgins CF, Gottesman MM. Is the multidrug transporter a flippase? Trends Biochem Sci. 1992;17:18-21.
36. Hindenburg AA, Gervasoni Jr JE, Krishna S et al. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res. 1989;49:4607-14.
37. Hoffmann MH, Roepe PD. Analysis of ion transport perturbations caused by hu MDR1 protein overexpression. Biochemistry. 1997;36:11153-68.
38. Hoffmann MH, Wei L-W, Roepe PD. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance? J Gen Physiol. 1996;107:295-313.
39. Horio M, Chin K-V, Currier SJ et al. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia. J Biol Chem. 1989;264: 14880-4.
40. Hunter J, Hirst BH, Simmons NL. Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T-84) layers expressing P-glycoprotein. Br J Cancer. 1991;64:437-44.
41. Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. J Biol Chem. 1993;268:14991-7.
42. Izquierdo MA, Scheffer GL, Flens MJ et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol. 1996;148:877-87.
43. Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 1994; 54:4833-6.
44. Keizer HG, Joenje H. Increased cytosolic pH in multidrug-resistant human lung tumor cells: effects of verapamil. J Natl Cancer Inst. 1989;81:706-9.
45. Lacave R, Ouar Z, Paulais M et al. Lysosomotropic agents increase vinblastine efflux from mouse mdr proximal kidney cells exhibiting vectorial drug transport. J Cell Physiol. 1999;178:247-57.
46. 4 and structurally related conjugates. J Biol Chem. 1994;269:27807-10.
47. Levielle-Webster CR, Arias IM. The biology of the P-glycoproteins. J Membr Biol. 1995;143:89-102.
48. Loe DW, Deeley RG, Cole SPC. Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer. 1996; 32A:945-57.
49. +)-ATPase subunit C is overexpressed in multidrug-resistant HL60 cells. Biochem Biophys Res Commun. 1992;182:675-81.
50. Mukhopadhyay K, Parrack PK, Bhattacharyya B. The carboxy terminus of the alpha subunit of tubulin regulates its interaction with colchicine. Biochemistry. 1990;29:6845-50.
51. Müller M, Meijer C, Zaman GJR et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA. 1994;91:13033-7.
52. Roepe PD. Analysis of the steady state and initial rate of doxorubicin efflux from a series of MDR cells expressing different levels of P-glycoprotein. Biochemistry. 1992;31: 12555-64.
53. Roepe PD, Wei LY, Cruz J, Cralson D. Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochemistry. 1993;32:11042-56.
54. Roninson IB. In: Roninson IB, ed. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press; 1991:199-211.
55. Roninson IB. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem Pharmacol. 1992;43:95-102.
56. Rosenberg MF, Callaghan R, Ford RC, Higgins CF. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J Biol Chem. 1997;16:10685-94.
57. Rutherford AV, Willingham MC. Ultrastructural localization of daunomycin in multidrug-resistant cultured cells with modulation of the multidrug transporter. J Histochem Cytochem. 1993;41:1573-7.
58. Schaub TP, Kartenbeck J, Konig J et al. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol. 1997;8:1213-21.
59. Scheffer GL, Wijngaard PL, Flens MJ et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med. 1995;1:78-82.
60. Schindler M, Grabski S, Hoff E, Simon SM. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). Biochemistry. 1996;35:2811-7.
61. Sehested M, Skovsgaard T, Van Deurs B, Winther-Nielsen H. Increase in nonspecific adsorptive endocytosis in anthracycline- and Vinca alkaloid-resistant Ehrlich ascites tumor cell lines. J Natl Cancer Inst. 1987;78:171-9.
62. Shapiro AB, Ling V. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J Biol Chem. 1994;269:3745-54.
63. Simon M, Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA. 1994a; 91:3497-504.
64. Simon M, Roy D, Schindler M. Intracellular pH and the control of multidrug-resistance. Proc Natl Acad Sci USA. 1994b;91:1128-32.
65. Spoelstra E, Westerhoff HV, Dekker H, Lankelma J. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells. Eur J Biochem. 1992;207:567-79.
66. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistant gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA. 1987;84:7735-8.
67. Thiebaut F, Currier SJ, Whitaker J et al. Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by microinjection of a pH-sensitive dye. J Histochem Cytochem. 1990;38:685-90.
68. Tsuruo T, Iida H, Tsukagoshi S, Sukarai, Y. Overcoming of vincristine resistance in P3888 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981;41:1967-72.
69. von Figura K, Hasilik A. Lysosomal enzymes and their receptors. Annu Rev Biochem. 1986;55:167-93.
70. Warren L, Jardillier JC, Ordentlich P. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells. Cancer Res. 1991;51:1996-2001.
71. Warren L, Malarska A, Jardillier JC. The structure of P-glycoprotein and the secretion of lysosomal enzymes in multidrug resistant cells. Cancer Chemother Pharmacol. 1995;35:267-9.
72. Wijnholds J, Evers R, van Leusden MR et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med. 1997;3:1275-9.
73. Woo J-T, Shinohara C, Sakai K, Hasumi K, Endo A. Isolation, characterization and biological activities of concanamycins as inhibitors of lysosomal acidification. J Antibiotics. 1992; 45:1108-16.
74. Zaman GJR, Versantvoort CHM, Smit JJM et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA. 1994;91:8822-6.
75. Zamora JM, Beck WT. Chloroquine enhancement of anticancer drug cytotoxicity in multiple resistant human leukemic cells. Biochem Pharmacol. 1986;35:4303-10.